38694-47-2

Basic information

• Product Name: 4-bromobutyraldehyde
• Synonyms: 4-Bromobutyraldehyde; 4-bromobutanal
• CAS NO: 38694-47-2
• Molecular Formula: C₄H₇BrO
• Molecular Weight: 151.0018
• EINECS: 254-090-3
• Mol File: 38694-47-2.mol
• Article Data: 53

Chemical Properties

• Boiling Point: 177°C at 760 mmHg
• Flash Point: 87.6°C
• Density: 1.437g/cm³
• Vapor Pressure: 1.06mmHg at 25°C
• Refractive Index: 1.454
• CAS DataBase Reference: 4-bromobutyraldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromobutyraldehyde(38694-47-2)
• EPA Substance Registry System: 4-bromobutyraldehyde(38694-47-2)

Safety Data

• Hazardous Substances Data: 38694-47-2(Hazardous Substances Data)

Usage

General Description

4-Bromobutyraldehyde is a chemical compound with the molecular formula C4H7BrO. It is a colorless to pale yellow liquid with a pungent, sweet odor. 4-Bromobutyraldehyde is used as a building block in the production of various pharmaceuticals, agrochemicals, and fine chemicals. It is also used as an intermediate in the synthesis of other organic compounds, such as 4-bromobutyric acid and 4-bromobutyric acid ethyl ester. 4-Bromobutyraldehyde is primarily utilized in the research and development of new chemical products and is also used in the manufacturing of flavors and fragrances. However, 4-Bromobutyraldehyde should be handled with care as it can cause irritation to the skin, eyes, and respiratory system if not used properly.

Upstream product

• 33036-62-3 4-Bromo-1-butanol 
• 2969-81-5 Ethyl 4-bromobutyrate 
• 1119-51-3 bromopentene 
• 5332-06-9 4-bromobutanenitrile 
• 78362-94-4 {PPN}{HCr(CO)5} 
• 927-58-2 4-bromobutyroyl chloride 
• 1310031-36-7 C₁₂H₂₁Br₃O₃ 
• 5162-44-7 1-bromo-4-butene 
• 76-09-5 2,3-dimethyl-2,3-butane diol 
• 31930-39-9 4-bromocrotonaldehyde 
• 4897-84-1 Methyl 4-bromobutyrate 
• 2623-87-2 bromobutyric acid 
• 109-99-9 tetrahydrofuran 
• 65032-47-5 cyclobutyl p-toluenesulfonamide 

Downstream Products

• 24157-02-6 4-bromo-1,1-dimethoxybutane 
• 62563-07-9 2-(3-bromopropyl)-1,3-dioxolane 
• 157491-70-8 4-bromobutanal dibenzyl acetal 
• 135415-89-3 (R)-2-hydroxy-2-methylhexanenitrile 
• 164472-76-8 (R)-(+)-5-bromo-2-hydroxypentanenitrile 
• 1174400-64-6 N-{4-bromo-1-[(4-methylphenyl)sulfonyl]butyl}-P,P-diphenylphosphinic amide 
• 1403666-74-9 2-(3-bromopropyl)-N,N-dimethyl-4,4-diphenyl-4H-benzo[d][1,3]dioxin-6-amine 
• 1185453-81-9 1-(1-(4-methoxyphenyl)pyrrolidin-2-yl)propan-2-one 
• 1155269-84-3 C₁₃H₂₄N₂O₃ 
• 5332-06-9 4-bromobutanenitrile 
• 539820-24-1 (S)-tetrahydrofuran-2-carbonitrile 
• 1393708-93-4 (R)-4-bromo-1-cyanobutyl acetate 
• 164472-78-0 (R)-(tetrahydrofuran-2-yl)carbonitrile 
• 14631-43-7 2-tetrahydrofuran-2-carbonitrile 

Relevant articles and documents

Design and Synthesis of Novel Macrocyclic Mer Tyrosine Kinase Inhibitors

Mer tyrosine kinase (MerTK) is aberrantly elevated in various tumor cells and has a normal anti-inflammatory role in the innate immune system. Inhibition of MerTK may provide dual effects against these MerTK-expressing tumors through reducing cancer cell survival and redirecting the innate immune response. Recently, we have designed novel and potent macrocyclic pyrrolopyrimidines as MerTK inhibitors using a structure-based approach. The most active macrocycles had an EC50 below 40 nM in a cell-based MerTK phosphor-protein ELISA assay. The X-ray structure of macrocyclic analogue 3 complexed with MerTK was also resolved and demonstrated macrocycles binding in the ATP binding pocket of the MerTK protein as anticipated. In addition, the lead compound 16 (UNC3133) had a 1.6 h half-life and 16% oral bioavailability in a mouse PK study.

A synthesis of (±)-stemoamide using the intramolecular propargylic Barbier reaction

A diastereoselective synthesis of the alkaloid stemoamide has been achieved using the intramolecular propargylic Barbier reaction to construct the seven-membered ring. Georg Thieme Verlag Stuttgart.

Evidence That Trimethyllysine Hydroxylase Catalyzes the Formation of (2S,3S)-3-Hydroxy-Nε-trimethyllysine

Trimethyllysine hydroxylase (TMLH) is an Fe(II) and 2-oxoglutarate (2OG) dependent oxygenase involved in the biomedically important carnitine biosynthesis pathway. A combination of synthetic and NMR studies provides direct evidence that human TMLH catalyzes the stereoselective conversion of (2S)-Nε-trimethyllysine to (2S,3S)-3-hydroxy-Nε-trimethyllysine.

2-(1-bromocyclobutyl) pyridine and synthesis method thereof

The invention belongs to the technical field of organic synthesis, and relates to 2- (1-bromocyclobutyl) pyridine and a synthesis method thereof. The 2 -(-1bromocyclobutyl) pyridine can be used as a medical intermediate, and the synthetic method of the compound comprises the following steps: by taking tetrahydropyrane- 2-ketone as a raw material, carrying out nine steps of reactions including substitution, ring closing, hydrolysis, substitution, substitution, reduction, grignard, substitution and substitution to prepare the 2- (-1bromocyclobutyl) pyridine, so that the synthetic route is simple, the cost is low, and the efficiency is high.

Palladium-Catalyzed Aerobic Anti-Markovnikov Oxidation of Aliphatic Alkenes to Terminal Acetals

Terminal acetals were selectively synthesized from various unbiased aliphatic terminal alkenes and 1,2-, 1,3-, or 1,4-diols using a PdCl2(MeCN)2/CuCl catalyst system in the presence of p-toluquinone under 1 atm of O2 and mild reaction conditions. The slow addition of terminal alkenes suppressed the isomerization to internal alkenes successfully. Electron-deficient cyclic alkenes, such as p-toluquinone, were key additives to enhance the catalytic activity and the anti-Markovnikov selectivity. The halogen groups in the alkenes were found to operate as directing groups, suppressing isomerization and increasing the selectivity efficiently.